The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 04, 2022
Filed:
Jan. 24, 2019
Applicant:
Amgen Inc., Thousand Oaks, CA (US);
Inventors:
Heather Arnett, Seattle, WA (US);
Sabine Schadow Escobar, Sammamish, WA (US);
Ryan Michael Swanson, Seattle, WA (US);
Joanne Louise Viney, Belmont, MA (US);
Assignee:
Amgen Inc., Thousand Oaks, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); C07K 16/46 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
C07K 14/705 (2013.01); A61K 39/0013 (2013.01); A61K 39/3955 (2013.01); C07K 14/70503 (2013.01); C07K 16/46 (2013.01); A61K 38/00 (2013.01); C07K 2319/30 (2013.01);
Abstract
The invention provides novel BTNL3 proteins, including multimers, fragments, fusion proteins, and variants. In addition, antibodies that can bind to BTNL3 proteins and nucleic acids encoding BTNL3 proteins are provided. Methods of making BTNL3 proteins using such nucleic acids are also provided. Uses for BTNL3 proteins, and agonists or antagonists thereof, are described.